A detailed history of Cibc Bancorp Usa Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 44,180 shares of MRNA stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,180
Holding current value
$1.09 Million
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 21, 2025

SELL
$23.51 - $34.67 $207,381 - $305,824
-8,821 Reduced 19.97%
35,359 $913,000
Q3 2025

Nov 12, 2025

BUY
$23.51 - $34.67 $1.04 Million - $1.53 Million
44,180 New
44,180 $1.14 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $9.69B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Cibc Bancorp Usa Inc. Portfolio

Follow Cibc Bancorp Usa Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Bancorp Usa Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc Bancorp Usa Inc. with notifications on news.